FindMyRecallSubscribe
Class I: serious health riskTerminated

Sandoz Methotrexate Injection Recall

Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose…

Sandoz Incorporated · Broomfield, CO

Risk level
Class I
Reported by FDA
Aug 14, 2013
Recall ID
D-832-2013
Check your lot numberHow we source this data

Summary

Sandoz recalled Methotrexate Injection starting May 20, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-832-2013 on Aug 14, 2013. Reason: Presence of Particulate Matter: Found during examination of retention samples. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Found during examination of retention samples.

Product description

Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540; Manufactured by: EBEWE Pharma Ges.m.b.H. Nfg.KG, A-4866 Unterach, AUSTRIA, NDC 66758-041-01.

Lot numbers, UPCs & expiration codes

Lot #: CL0996, Exp 12/13; and CJ4948, Exp 05/13

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-832-2013
Classification
Class I
Status
Terminated
Recall initiated
May 20, 2013
FDA report date
Aug 14, 2013
Quantity
1,635 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz Incorporated

Original FDA data

Every field from FDA enforcement report D-832-2013, exactly as published.

Show all FDA fields
City
Broomfield
State
CO
Status
Terminated
Country
United States
Event ID
65200
Address
2555 W Midway Blvd
Code information
Lot #: CL0996, Exp 12/13; and CJ4948, Exp 05/13
Postal code
80020-1632
Report date
Aug 14, 2013
Product type
Drugs
Recall number
D-832-2013
Classification
Class I
Recalling firm
Sandoz Incorporated
Product quantity
1,635 vials
Termination date
Jan 29, 2014
Reason for recall
Presence of Particulate Matter: Found during examination of retention samples.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540; Manufactured by: EBEWE Pharma Ges.m.b.H. Nfg.KG, A-4866 Unterach, AUSTRIA, NDC 66758-041-01.
Distribution pattern
Nationwide
Recall initiation date
May 20, 2013
Initial firm notification
Press Release
Center classification date
Aug 2, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-832-2013, published Aug 14, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls